Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CoLucid Pharmaceuticals, Inc. (CLCD) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/19/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/13/2017 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
03/06/2017 EFFECT Form EFFECT - Notice of Effectiveness
03/02/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/02/2017 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
03/02/2017 POS AM Form POS AM - Post-Effective amendments for registration statement
03/02/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/01/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
03/01/2017 8-K Quarterly results
03/01/2017 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
03/01/2017 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
02/14/2017 SC TO-T/A Form SC TO-T/A - Tender offer statement by Third Party [Amend]
02/14/2017 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
02/10/2017 SC 13G/A CoLucid Pharmaceuticals, Inc. reports a 0% stake in CoLucid Pharmaceuticals, Inc.
02/10/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/07/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
02/02/2017 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership
01/31/2017 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
01/31/2017 SC TO-T Form SC TO-T - Tender offer statement by Third Party
01/27/2017 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership
01/26/2017 SC 13G CoLucid Pharmaceuticals, Inc. reports a 7.3% stake in CoLucid Pharmaceuticals, Inc.
01/18/2017 SC TO-C Form SC TO-C - Written communication relating to an issuer or third party
01/18/2017 8-K Form 8-K - Current report
01/18/2017 SC14D9C Form SC14D9C - Written communication relating to third party tender offer
01/09/2017 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
11/09/2016 8-K Form 8-K - Current report
11/09/2016 10-Q Quarterly Report for the period ended September 30, 2016
10/12/2016 8-K Form 8-K - Current report
10/11/2016 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend]
09/14/2016 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
09/09/2016 8-K Form 8-K - Current report
09/09/2016 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
09/08/2016 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
09/08/2016 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy